Organigram (TSE:OGI) Shares Up 2% - Still a Buy?

Key Points

• Shares rose 2% intraday to C$2.05 (high C$2.07) on volume of 230,977 shares, roughly 8% above average trading volume.
• Wall Street consensus is a Buy with an average target of C$3.13; Canaccord set C$3.00 (buy) while ATB Cormark downgraded to "moderate buy" and trimmed its target to C$3.25.
• Notable insider selling: a director sold 17,929 shares at C$1.86 and insiders have sold 76,647 shares in the past 90 days, though insiders still own 31.32% of the company.

Shares of Organigram Holdings Inc. (TSE:OGI - Get Free Report) shot up 2% during mid-day trading on Monday . The stock traded as high as C$2.07 and last traded at C$2.05. 230,977 shares traded hands during trading, an increase of 8% from the average session volume of 214,491 shares. The stock had previously closed at C$2.01.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on OGI. Canaccord Genuity Group set a C$3.00 price target on shares of Organigram and gave the company a "buy" rating in a report on Tuesday, January 27th. ATB Cormark Capital Markets downgraded shares of Organigram from a "strong-buy" rating to a "moderate buy" rating and cut their price target for the company from C$3.50 to C$3.25 in a report on Wednesday, February 11th. Two research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company currently has an average rating of "Buy" and an average target price of C$3.13.

Organigram Stock Up 2.0%

The stock has a market capitalization of C$288.30 million, a P/E ratio of 13.31, a P/E/G ratio of 0.42 and a beta of 1.54. The firm's fifty day moving average is C$1.92 and its 200-day moving average is C$2.19. The company has a current ratio of 2.73, a quick ratio of 2.62 and a debt-to-equity ratio of 2.29.

Insider Transactions at Organigram

In related news, Director Donald Geoffrey Machum sold 17,929 shares of Organigram stock in a transaction dated Wednesday, March 25th. The shares were sold at an average price of C$1.86, for a total transaction of C$33,347.94. Following the completion of the transaction, the director directly owned 1,125 shares of the company's stock, valued at C$2,092.50. This trade represents a 94.10% decrease in their position. Over the last ninety days, insiders have sold 76,647 shares of company stock worth $142,753. Company insiders own 31.32% of the company's stock.

Organigram Company Profile

Organigram Inc is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.